<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[NOVO — Oktober 2023]]></title><description><![CDATA[<p dir="auto">God morgen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400302/novo-oktober-2023</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 09:37:39 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400302.rss" rel="self" type="application/rss+xml"/><pubDate>Sun, 01 Oct 2023 04:21:45 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Tue, 31 Oct 2023 16:40:51 GMT]]></title><description><![CDATA[<p dir="auto">The Ozempic Effect Is Coming for Everything From Kidney to Heart Disease Treatments</p>
<p dir="auto">It could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s. <a href="https://www.bloomberg.com/news/features/2023-10-18/glp-1-drug-benefits-like-ozempic-go-beyond-weight-loss?utm_medium=cpc_social&amp;utm_source=twitter&amp;utm_campaign=BLOM_ENG_WEEKLYX_Y0469_TW_SO_WTRF_BROADXXXXX_KEYCO_00XXXXCPC_2PTW_XXXX_BUSFINLUXREAD_X1854_Y0469_XXXEN_TWITOA_OZEM_BW_EN_PG_NFLINKS&amp;twclid=2-ga9fpxbfg0alvly9tknv" rel="nofollow ugc">https://www.bloomberg.com/news/features/2023-10-18/glp-1-drug-benefits-like-ozempic-go-beyond-weight-loss?utm_medium=cpc_social&amp;utm_source=twitter&amp;utm_campaign=BLOM_ENG_WEEKLYX_Y0469_TW_SO_WTRF_BROADXXXXX_KEYCO_00XXXXCPC_2PTW_XXXX_BUSFINLUXREAD_X1854_Y0469_XXXEN_TWITOA_OZEM_BW_EN_PG_NFLINKS&amp;twclid=2-ga9fpxbfg0alvly9tknv</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980296</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980296</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 31 Oct 2023 16:40:51 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Tue, 31 Oct 2023 09:05:56 GMT]]></title><description><![CDATA[<p dir="auto">Ozempic Just Shrugged Off a Challenge From Viatris. What Does This Mean for Investors? <a href="https://www.proinvestor.com/investornyt/1071604/ozempic-just-shrugged-off-a-challenge-from-viatris-what-does-this-mean-for-investors" rel="nofollow ugc">https://www.proinvestor.com/investornyt/1071604/ozempic-just-shrugged-off-a-challenge-from-viatris-what-does-this-mean-for-investors</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980295</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980295</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 31 Oct 2023 09:05:56 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 30 Oct 2023 06:33:57 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk får lagt over 22 pct. til kursmålet hos Carnegie<br />
30.10.2023 07.49 • MarketWire •<br />
Novo Nordisks kursmål er blevet hævet til 785 kr. fra 642,50 kr. hos investeringsbanken Carnegie.</p>
<p dir="auto">Det fremgår af Bloomberg News.</p>
<p dir="auto">Anbefalingen er uændret "køb".</p>
<p dir="auto">Novo-aktien bakkede fredag 2,4 pct. til 660,20 kr.</p>
<p dir="auto">.\˙ MarketWire</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980294</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980294</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 30 Oct 2023 06:33:57 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 30 Oct 2023 06:16:50 GMT]]></title><description><![CDATA[<p dir="auto">Nordea gentager køb af Novo med kursmål 787.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980292</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980292</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Mon, 30 Oct 2023 06:16:50 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 30 Oct 2023 06:15:39 GMT]]></title><description><![CDATA[<p dir="auto">"Novo Nordisks kursmål er blevet hævet til 785 kr. fra 642,50 kr. hos investeringsbanken Carnegie."</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980293</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980293</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Mon, 30 Oct 2023 06:15:39 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Fri, 27 Oct 2023 18:45:12 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk varmer op til stor udvidelse i USA <a href="https://borsen.dk/nyheder/virksomheder/novo-nordisk-varmer-op-til-stor-udvidelse-i-usa?b_source=borsen&amp;b_medium=row_1&amp;b_campaign=news_2" rel="nofollow ugc">https://borsen.dk/nyheder/virksomheder/novo-nordisk-varmer-op-til-stor-udvidelse-i-usa?b_source=borsen&amp;b_medium=row_1&amp;b_campaign=news_2</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980288</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980288</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Fri, 27 Oct 2023 18:45:12 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Fri, 27 Oct 2023 10:47:46 GMT]]></title><description><![CDATA[<p dir="auto">"Lægemiddelagentur ser ikke dokumentation for, at Novo Nordisk-midler giver øget risiko for kræft."<br />
<a href="https://www.bt.dk/erhverv/novos-populaere-slankemiddel-viser-ikke-tegn-paa-oeget-kraeftrisiko" rel="nofollow ugc">https://www.bt.dk/erhverv/novos-populaere-slankemiddel-viser-ikke-tegn-paa-oeget-kraeftrisiko</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980287</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980287</guid><dc:creator><![CDATA[NiklasZ]]></dc:creator><pubDate>Fri, 27 Oct 2023 10:47:46 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Tue, 24 Oct 2023 12:58:09 GMT]]></title><description><![CDATA[<p dir="auto">Jeg er optimist...og tror på det:-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980297</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980297</guid><dc:creator><![CDATA[AaBforever]]></dc:creator><pubDate>Tue, 24 Oct 2023 12:58:09 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Tue, 24 Oct 2023 12:07:31 GMT]]></title><description><![CDATA[<p dir="auto">Det er en meget forsimplet model han benytter, som jeg ikke nødvendigvis er enig. Men hvis der på noget tidspunkt skal komme et europæisk selskab der bryder $1.000 mia grænsen, så er novo bestemt et godt bud derpå</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980286</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980286</guid><dc:creator><![CDATA[troldmanden]]></dc:creator><pubDate>Tue, 24 Oct 2023 12:07:31 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Tue, 24 Oct 2023 12:05:42 GMT]]></title><description><![CDATA[<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://seekingalpha.com/article/4642776-novo-nordisk-growing-to-potentially-become-the-first-trillion-dollar-european-champion">
Access to this page has been denied
</a>
</h5>
<p class="card-text line-clamp-3">px-captcha</p>
</div>
<a href="https://seekingalpha.com/article/4642776-novo-nordisk-growing-to-potentially-become-the-first-trillion-dollar-european-champion" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://seekingalpha.com/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>



<p class="d-inline-block text-truncate mb-0"> <span class="text-secondary">(seekingalpha.com)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980291</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980291</guid><dc:creator><![CDATA[troldmanden]]></dc:creator><pubDate>Tue, 24 Oct 2023 12:05:42 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Tue, 24 Oct 2023 12:05:34 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk: Growing To Potentially Become The First Trillion-Dollar European Champion</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980284</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980284</guid><dc:creator><![CDATA[troldmanden]]></dc:creator><pubDate>Tue, 24 Oct 2023 12:05:34 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Tue, 24 Oct 2023 10:01:08 GMT]]></title><description><![CDATA[<p dir="auto">Hvis man kun ser overskriften, så lyder det da voldsomt, men det er så på seks<br />
år, han har tjent det.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980282</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980282</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Tue, 24 Oct 2023 10:01:08 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Tue, 24 Oct 2023 06:16:35 GMT]]></title><description><![CDATA[<p dir="auto">Novo-topchefs løn runder halv milliard kronerhttps://www.berlingske.dk/business/business-overblik-novo-topchefs-loen-runder-halv-milliard-kroner</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980290</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980290</guid><dc:creator><![CDATA[Urban]]></dc:creator><pubDate>Tue, 24 Oct 2023 06:16:35 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 13:45:01 GMT]]></title><description><![CDATA[<p dir="auto">Ja det tror du bestemt du har ret i. Novo må være lidt proaktive og hjælpe med den samfundsmæssige besparelser. De kan jo starte med at inkludere besparelse pga 20% RRR i CVD.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980283</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980283</guid><dc:creator><![CDATA[lahn1]]></dc:creator><pubDate>Mon, 23 Oct 2023 13:45:01 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 13:21:52 GMT]]></title><description><![CDATA[<p dir="auto">Fedt lahn1, det er vel for meget at håbe på, at regionernes lægefaglige direktører hører denne podcast?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980281</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980281</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Mon, 23 Oct 2023 13:21:52 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 13:05:23 GMT]]></title><description><![CDATA[<p dir="auto">super mange tak;-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980280</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980280</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Mon, 23 Oct 2023 13:05:23 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 12:55:35 GMT]]></title><description><![CDATA[<p dir="auto">Spotify link <a href="https://spotify.link/qUa5u3ll8Db" rel="nofollow ugc">https://spotify.link/qUa5u3ll8Db</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980279</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980279</guid><dc:creator><![CDATA[lahn1]]></dc:creator><pubDate>Mon, 23 Oct 2023 12:55:35 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 12:42:48 GMT]]></title><description><![CDATA[<p dir="auto">Kan anbefale at høre Børsen seneste podcast i serien ” Topchefernes strategi” med Niels Lunde, som denne gang handler om Novo. <a href="https://www.podbean.com/ep/pb-g3ep8-14d5e17" rel="nofollow ugc">https://www.podbean.com/ep/pb-g3ep8-14d5e17</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980277</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980277</guid><dc:creator><![CDATA[lahn1]]></dc:creator><pubDate>Mon, 23 Oct 2023 12:42:48 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 12:35:16 GMT]]></title><description><![CDATA[<p dir="auto">nu er ideen givet videre:-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980289</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980289</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Mon, 23 Oct 2023 12:35:16 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 12:32:38 GMT]]></title><description><![CDATA[<p dir="auto">og hvad sparer Regioner som følge af alle de positive effekter Wegovy ?, men det er vel et alt for svært spørgsmål at stille for JP´s journalist:-(</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980275</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980275</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Mon, 23 Oct 2023 12:32:38 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 04:54:30 GMT]]></title><description><![CDATA[<p dir="auto">em 24 og 28 milliarder kroner årligt, skriver Jyllands-Posten.</p>
<p dir="auto">/ritzau/</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980273</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980273</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 23 Oct 2023 04:54:30 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 04:54:03 GMT]]></title><description><![CDATA[<p dir="auto">Det kan imidlertid ikke lade sig gøre i den almene praksis, men ifølge formanden er der flere andre aktører, der er villige til at udskrive medicinen til folk uden for målgruppen. Han nævner ingen konkrete aktører.</p>
<p dir="auto">Lægemiddelstyrelsen har tidligere afvist at give tilskud til medicinen, da den ikke fandt, at prisen på Wegovy modsvarede lægemidlets behandlingsværdi.</p>
<p dir="auto">Hvis alle svært overvægtige skulle have offentligt tilskud til medicinen, vil det ifølge Sundhedsministeriet koster regionerne mell</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980278</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980278</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 23 Oct 2023 04:54:03 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 04:53:49 GMT]]></title><description><![CDATA[<p dir="auto">PLO skønner, at medicinen alene i år vil føre til cirka 400.000 ekstra konsultationer hos de praktiserende læger. Det fremgår ikke, hvordan organisationen er nået frem til det estimat.</p>
<p dir="auto">Formand Jørgen Skadborg fortæller, at det ikke kun er patienter inden for målgruppen, der henvender sig i håbet om at få en recept.</p>
<p dir="auto">Det sker også jævnligt, at normalvægtige har et ønske om at få udskrevet medicinen, lyder det.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980272</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980272</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 23 Oct 2023 04:53:49 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Oktober 2023 on Mon, 23 Oct 2023 04:53:26 GMT]]></title><description><![CDATA[<p dir="auto">Størstedelen af recepterne er udskrevet af de praktiserende læger.</p>
<p dir="auto">Det er muligt for læger at udskrive medicinen til svært overvægtige patienter med et BMI over 30.</p>
<p dir="auto">Overvægtige med et BMI på mellem 27 og 30 må også få Wegovy udskrevet, hvis de på samme tid har helbredsproblemer, der er vægtrelaterede.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7980271</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7980271</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 23 Oct 2023 04:53:26 GMT</pubDate></item></channel></rss>